1,750
Participants
Start Date
July 14, 2016
Primary Completion Date
December 14, 2018
Study Completion Date
December 14, 2018
Blood sample collection
All participants will have an enrolment visit with collection of a blood sample and a termination contact/visit. Participants or their parents/guardians will be contacted weekly or every two weeks to monitor the occurrence of febrile episodes. Additional visits will be made if febrile episodes occur. In case of dengue suspicion, a blood sample will be collected.
GSK Investigational Site, City of Muntinlupa
GSK Investigational Site, Zapopan
Lead Sponsor
GlaxoSmithKline
INDUSTRY